| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.66.2.554 |
| P698 | PubMed publication ID | 2137041 |
| P2093 | author name string | K Schwartz | |
| A M Lompré | |||
| J J Mercadier | |||
| L Rappaport | |||
| F Marotte | |||
| C Wisnewsky | |||
| D de la Bastie | |||
| D Levitsky | |||
| V Brovkovich | |||
| P433 | issue | 2 | |
| P304 | page(s) | 554-564 | |
| P577 | publication date | 1990-02-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat | |
| P478 | volume | 66 |
| Q34656730 | A novel E box/AT-rich element is required for muscle-specific expression of the sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene |
| Q36187399 | A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program |
| Q35599387 | Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure |
| Q41981503 | Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961. |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q35599413 | Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium |
| Q74591958 | Alterations of cross-bridge kinetics in human atrial and ventricular myocardium |
| Q73131028 | Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure |
| Q42928967 | Assessment of intra-SR free [Ca] and buffering in rat heart |
| Q31754860 | Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil |
| Q70517013 | Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat |
| Q39493909 | Ca2+ cycling and new therapeutic approaches for heart failure |
| Q36453453 | Ca2+ extrusion across plasma membrane and Ca2+ uptake by intracellular stores |
| Q34195822 | Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure |
| Q51727126 | Calcium accumulation and release by the sarcoplasmic reticulum of digitonin-lysed adult mammalian ventricular cardiomyocytes |
| Q35225687 | Calcium pump isoforms: Diversity, selectivity and plasticity |
| Q40958592 | Calcium transport proteins in the nonfailing and failing heart: gene expression and function |
| Q37364786 | Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. |
| Q48008623 | Calcium uptake by the sarcoplasmic reticulum, high energy content and histological changes in ischemic cardiomyopathy |
| Q52097997 | Cardiac expression of Gal4 causes cardiomyopathy in a dose-dependent manner. |
| Q35395744 | Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes |
| Q36554735 | Cellular mechanisms of arrhythmogenic cardiac alternans |
| Q37079362 | Changes in Gene Expression during Cardiac Growth |
| Q74436191 | Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features |
| Q35802086 | Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts |
| Q70939401 | Decrease in beta 1-adrenergic and M2-muscarinic receptor mRNA levels and unchanged accumulation of mRNAs coding for G alpha i-2 and G alpha s proteins in rat cardiac hypertrophy |
| Q34177840 | Decreased Gs alpha mRNA levels accompany the fall in Gs and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses |
| Q42953996 | Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals |
| Q71918853 | Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction |
| Q42470529 | Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban |
| Q73129855 | Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade |
| Q48055430 | Differences in sarcoplasmic reticulum gene expression in myocardium from patients undergoing cardiac surgery. Quantification of steady-state levels of messenger RNA using the reverse transcription-polymerase chain reaction |
| Q90102589 | Differential expression of genes participating in cardiomyocyte electrophysiological remodeling via membrane ionic mechanisms and Ca2+-handling in human heart failure |
| Q77398576 | Effect of myocardial hypertrophy on systolic and diastolic function in children: insights from the force-frequency and relaxation-frequency relationships |
| Q43255247 | Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy |
| Q74436242 | Effects of norepinephrine on expression of IGF-1/IGF-1R and SERCA2 in rat heart |
| Q60153641 | Expression and Localization of the Annexins II, V and VI in Myocardium from Patients with End-Stage Heart Failure |
| Q35821927 | Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure |
| Q35371129 | Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. |
| Q60425250 | Gender differences in molecular remodeling in pressure overload hypertrophy |
| Q41252644 | Gene expression of the Na-Ca exchanger in cardiac hypertrophy |
| Q34623700 | Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth |
| Q34224023 | Glycolytic inhibition: effects on diastolic relaxation and intracellular calcium handling in hypertrophied rat ventricular myocytes |
| Q38574015 | Heart Failure with Normal Systolic Function: A Common Disorder in Older People |
| Q89964430 | Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes |
| Q47671855 | Human SERCA2a levels correlate inversely with age in senescent human myocardium |
| Q45039254 | Increased cardiac workload by closure of the ductus arteriosus leads to hypertrophy and apoptosis rather than to hyperplasia in the late fetal period |
| Q35817405 | Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation |
| Q77582078 | Influence of different culture conditions on sarcoplasmic reticular calcium transport in isolated neonatal rat cardiomyocytes |
| Q72772542 | Involvement of the sarcoplasmic reticulum calcium pump in myocardial contractile dysfunction: comparison between chronic pressure-overload and stunning |
| Q33701944 | Matrix elasticity regulates the optimal cardiac myocyte shape for contractility |
| Q37025197 | Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling |
| Q41252605 | Molecular basis of the regression of cardiac hypertrophy |
| Q67900238 | Myocardial Ca-sequestration failure and compensatory increase in Ca-ATPase with congestive cardiomyopathy: kinetic characterization by a homogenate microassay using real-time ratiometric indo-1 spectrofluorometry |
| Q33825289 | Myocyte contractile dysfunction with hypertrophy and failure: relevance to cardiac surgery |
| Q37370078 | Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation |
| Q44692654 | Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan |
| Q35146909 | Pathogenetic basis of myocardial dysfunction and amenability to reversal |
| Q38808228 | Protective effects of appropriate Zn(2+) levels against UVB radiation-induced damage in human lens epithelial cells in vitro |
| Q52207265 | Quantification in crude homogenates of rat myocardial Na+, K(+)- and Ca(2+)-ATPase by K+ and Ca(2+)-dependent pNPPase. Age-dependent changes. |
| Q26742055 | Recent advances in understanding cardiac contractility in health and disease |
| Q34114279 | Recent developments in gene therapy for cardiac disease |
| Q73195038 | Reduced concentration of myocardial Na+,K(+)-ATPase in human aortic valve disease as well as of Na+,K(+)- and Ca(2+)-ATPase in rodents with hypertrophy |
| Q64038902 | Reduction of calcium-independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes |
| Q37003258 | Regulation of Cardiac Muscle Function in the Hypertensive Heart |
| Q41062649 | Regulation of expression of cardiac sarcoplasmic reticulum proteins under pathophysiological conditions |
| Q33727613 | Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy |
| Q37054922 | Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation |
| Q46112930 | Sarcoplasmic reticulum Ca(2+)-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice |
| Q71665345 | Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy |
| Q72075555 | Sarcoplasmic reticulum calcium transport and Ca(2+)-ATPase gene expression in thoracic and abdominal aortas of normotensive and spontaneously hypertensive rats |
| Q40565740 | Sarcoplasmic reticulum calsequestrins: structural and functional properties |
| Q48008693 | Sarcoplasmic reticulum in heart failure: central player or bystander? |
| Q71817485 | Sensitivity of cardiac tissues with moderate and advanced hypertrophy to calcium ions |
| Q42744793 | Spontaneously hypertensive rats and platelet Ca(2+)-ATPases: specific up-regulation of the 97 kDa isoform |
| Q42162747 | Tead1 is required for maintaining adult cardiomyocyte function, and its loss results in lethal dilated cardiomyopathy. |
| Q83207707 | The Sarco(endo)plasmic Reticulum Ca(2+)-ATPases in the Cardiovascular System During Growth and Proliferation |
| Q40920738 | The cardiac renin-angiotensin system: physiological relevance and pharmacological modulation. |
| Q37229784 | The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases |
| Q41787009 | The density of ryanodine receptors decreases with pressure overload-induced rat cardiac hypertrophy |
| Q74547978 | The sarco(endo)plasmic reticulum Ca(2+)-ATPase gene is regulated at the transcriptional level during compensated left ventricular hypertrophy in the rat |
| Q35090364 | The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases |
| Q37372872 | Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts |
| Q39008988 | Transmural gradients of myocardial structure and mechanics: Implications for fiber stress and strain in pressure overload |
| Q40475658 | Use of beta-adrenoceptor blockers in patients with congestive heart failure |
Search more.